openPR Logo
Press release

PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files

06-11-2009 03:01 PM CET | Science & Education

Press release from: PREMIER Biosoft International

PREMIER Biosoft International Releases version 4.50

Palo Alto, California – June 1, 2009- PREMIER Biosoft International today announced the world wide release of SimVector version 4.50. The new version includes support for loading Vector NTI® DNA (*.gb) files. Simply select File>Open>Sequence>From File and browse to the file location, no need to import or archive files. SimVector loads the sequence, reads the annotations and automatically scan all the analysis results performed in Vector NTI®.

The analysis information such as restriction analysis, ORF search and component fragment information is presented under separate tabs: features under the Feature tab, enzyme information under the Enzyme tab, ORF information under the ORF tab and component fragment information under the Note tab. This enables the data to be properly organized and in a format so that it is easily accessible.

“With this release, we are offering a cost effective but a powerful tool to all users who have their cloning research based on Vector NTI®.” said Kay Brown, V.P. Business Development and Marketing.

For details, please visit: http://www.premierbiosoft.com/plasmid_maps/VectorNTI.html

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.

Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com

Founded in 1994, is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. Our goal is to study the most recent innovations in molecular biology and translate them into software products that aid the biologist.

PREMIER Biosoft International
3786 Corina Way
Palo Alto CA 94303-4504
USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files here

News-ID: 83370 • Views: 855

More Releases from PREMIER Biosoft International

PREMIER Biosoft Announces Reseller Agreement with Bruker to Advance Lipidomics a …
PREMIER Biosoft, a next generation leader in bioinformatics, and Bruker Corporation (NASDAQ: BRKR) today announced that they have entered a reselling agreement pursuant to which Bruker will co-market and resell Premier's SimLipid and SimMet, high throughput informatics tools for lipid and metabolite data analysis. Integration with Bruker's mass spectrometric workflows will enable new powerful ways for researchers to seamlessly generate, process, and analyze data. Bruker's instruments produce highly accurate broad
PREMIER Biosoft Delivers Version 2.0 of OligoEvaluator™ to Sigma Life Science
Palo Alto, California -- PREMIER Biosoft, delivered OligoEvaluator™ 2.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, a leading Life Science and High Technology company conducts operations in 37 countries and provides biochemical and organic chemical products for scientific and genomic research. The new release of OligoEvaluator™ offers analysis of physico-chemical properties of multiple DNA or RNA sequences in a single search run
PREMIER Biosoft announces the release of SimGlycan® Enterprise Edition 5.0 to s …
Palo Alto, California : PREMIER Biosoft, a next generation leader in bioinformatics, today announced the release of Enterprise Edition of SimGlycan® v. 5.0, a comprehensive high throughput tool to provide support for glycan quantitation using Thermo Scientific™ aminoxyTMT™ for MS/MS glycan data analysis workflows. Additionally, it can be used for processing of LC-MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor m/z
PREMIER Biosoft announces the release of SimGlycan® v. 5.0 to provide informati …
Palo Alto, California – May 21, 2014: PREMIER Biosoft, a next generation leader in bioinformatics today announced the release of a new version of SimGlycan®, a comprehensive, high throughput tool to provide automated informatics support for LC-MS and MS/MS glycan data analysis workflows. The new version of the software facilitates processing of LC-MS and MS/MS data for peak detection, peak picking and alignment of glycans based on retention time, precursor

All 5 Releases


More Releases for Vector

Global Vector Network Analyzer Market Research Report - Forecast to 2023
Vector Network Analyzer Market 2020 comprises a detailed survey of the Vector Network Analyzer Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Vector Network Analyzer" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Vector Network Analyzer market in terms of thriving companies, business methods, product
Cigarillos Market Analysis 2025| Altria| British American Tobacco| Vector Group
HTF MI released a new market study on Global Cigarillos Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for
Vector Network Analyzer Market Recent Enhancements and Global Briefing 2018
Global Vector Network Analyzer Market Research Report 2018 This report studies Vector Network Analyzer Market in Worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million USD) and volume (Unit). Both top-down and bottom-up approaches have been used to estimate
Global Vector Signal Generator Market 2018 - Anritsu, Fortive, Keysight Technolo …
Apex Market Reports, recently published a detailed market research study focused on the “Vector Signal Generator Market” across the global, regional and country level. The report provides 360° analysis of “Vector Signal Generator Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Vector
Vector Network Analyzer Market Estimated to Flourish at by 2025
A radio frequency analyzer or a network analyzer is the device for analyzing the electric networks parameters. The device is the combination of hardware and software. A recent report published by Persistence Market Research reveals various factors influencing the growth of the market as well as numerous trends driving growth of the market. Number of parameter associated with the market were considered while forecasting dynamics of the market, and based
Global Viral Vector Development Service Market
The Viral Vector Development Service Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Owing to the immense potential of gene therapy, the use of viral vectors has increased significantly over the years. In order to fulfill the current need of viral vectors,